X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian stock markets continue to trade firm 
(Fri, 16 Dec 01:30 pm) 
 
Indian stock market continued to trade firm on account of sustained buying interest in heavyweights over the last two hours of trade. Barring capital goods, all the sectors are trading in the green. Stocks from Auto and Consumer durables space are witnessing maximum buying interest.

The BSE-Sensex is up by 176 points, while the NSE-Nifty is up 59 points. BSE Mid Cap index and the BSE Small Cap index are up by 0.64% and 0.57% respectively. The rupee is trading at 52.84 to the US dollar.

Steel stocks are mainly trading in the green with Tayo Rolls and Hindustan Zinc leading the pack of gainers. As per a leading financial daily, Steel Authority of India Ltd (SAIL) is seeking to acquire coking coal assets in Australia. As per the management, the company already sources 10 million tonnes from Australia and expects a boost in investment if it gets access to loans at competitive rates from the local banks in Australia. The Australian minister has suggested that there is a possibility to facilitate this by working out a way to offer loans to Indian ventures from Australia's large super annuation fund. However, this would need a thorough discussion between both the governments. It is important to note here that Australia accounts for around 80% of the coking coal used by steel industry. The stock was trading in the green

Pharma Stocks are trading mixed with Cipla and Divis Laboratories leading the pack of gainers and Biocon leading the losers. As per a leading financial daily, Ranbaxy Laboratories has received permission from US Food and Drug Administration (USFDA) to sell its generic drug acetaminophen in the US that happens to be world's largest drug market. Acetaminophen is used in case of headaches and other minor aches and pains. Recently, the company has been able to secure 2.5% market share in generic Lipitor segment in US the initial few days of launching the drug there. The stock was trading in the green.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian stock markets continue to trade firm". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Sep 26, 2017 03:35 PM

MARKET STATS